CDH2 and breast cancer: Western blotting analysis confirmed that siFXR reversed TGF-β1-induced metastasis of breast cancer cells by downregulating mesenchymal markers (N-cadherin and vimentin) and upregulating the epithelial marker E-Cadherin.